⌘K

Login Start Free

Home/Filings/4/0001062993-10-001255

4//SEC Filing

Geller Matthew 4

Accession 0001062993-10-001255

CIK 0000875622other

View on SEC.gov Company Profile

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 2:11 PM ET

Size

14.5 KB

Accession

0001062993-10-001255

Insider Transaction Report

Form 4

Period: 2010-04-15

BIOSPECIFICS TECHNOLOGIES CORPBSTC

Director

Transactions

Exercise/Conversion
Common Stock
2010-04-15$19.00/sh+15,000$285,000→ 30,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2010-04-15−15,000→ 0 total
Exercise: $19.00From: 2009-09-21Exp: 2018-09-21→ Common Stock, $.001 par value (15,000 underlying)
Exercise/Conversion
Common Stock
2010-04-15$19.00/sh+15,000$285,000→ 15,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2010-04-15−15,000→ 15,000 total
Exercise: $19.00From: 2009-09-21Exp: 2018-09-21→ Common Stock, $.001 par value (15,000 underlying)

Documents

2 files

Issuer

BIOSPECIFICS TECHNOLOGIES CORP

CIK 0000875622

Entity typeother

Related Parties

1

filerCIK 0001446201

Filing Metadata

Form type: 4
Filed: Apr 15, 8:00 PM ET
Accepted: Apr 16, 2:11 PM ET
Size: 14.5 KB

View on SEC.gov